In their study, they investigated the relationship between osteopontin expression and clinicopathological factors in stage I to stage IV ESCC patients after operation by immunohistochemical staining and enzyme immunoassay. The gene discussed is SPP1; the disease is esophageal squamous cell carcinoma.